We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

52 hedge funds and large institutions have $20.7M invested in NantHealth, Inc in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

11% more funds holding

Funds holding: 4752 (+5)

35% less capital invested

Capital invested by funds: $31.6M → $20.7M (-$10.9M)

37% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
12
Reduced
19
Closed
6
Calls
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$3K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$6.98M -$1.33M -25,082 -14%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.18M -$1.4M -26,350 -36%
Blackstone Inc
3
Blackstone Inc
New York
$1.82M
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.66M
Geode Capital Management
5
Geode Capital Management
Massachusetts
$993K +$55K +1,038 +5%
HCM
6
Highbridge Capital Management
New York
$672K -$105K -1,975 -12%
Morgan Stanley
7
Morgan Stanley
New York
$615K -$74.6K -1,407 -9%
WCM
8
Wildcat Capital Management
New York
$611K -$136K -2,564 -16%
Northern Trust
9
Northern Trust
Illinois
$609K +$26.5K +500 +4%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$510K -$318 -6 -0.1%
State Street
11
State Street
Massachusetts
$498K +$74.7K +1,408 +15%
AG
12
Advisor Group
Arizona
$450K +$522K +9,847 New
Millennium Management
13
Millennium Management
New York
$344K +$399K +7,519 New
Goldman Sachs
14
Goldman Sachs
New York
$292K -$146K -2,762 -30%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$270K
SG Americas Securities
16
SG Americas Securities
New York
$221K +$157K +2,958 +158%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$195K +$2.76K +52 +1%
ProShare Advisors
18
ProShare Advisors
Maryland
$185K -$32.5K -613 -13%
DekaBank Deutsche Girozentrale
19
DekaBank Deutsche Girozentrale
Germany
$176K
TCIM
20
TIAA CREF Investment Management
New York
$139K -$8.11K -153 -5%
Deutsche Bank
21
Deutsche Bank
Germany
$137K +$87.1K +1,643 +118%
Citadel Advisors
22
Citadel Advisors
Florida
$103K +$120K +2,260 New
Renaissance Technologies
23
Renaissance Technologies
New York
$99K -$72.4K -1,366 -39%
TA
24
Teachers Advisors
New York
$96K
Charles Schwab
25
Charles Schwab
California
$94K -$46.3K -874 -30%

NH Hedge Fund Activity: Q4 2017 in Review

52 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q4 2017, worth a combined $20.7M — down 35% from $31.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NH positions and 6 closed out — a net gain of 5 holders — while 12 added to existing stakes and 19 trimmed.

The largest buyer was Advisor Group, opening a new position worth an estimated $522K. The largest seller was Vanguard Group, cutting an estimated $1.4M.

  • 52 institutional investors held NantHealth, Inc (NH) as of Q4 2017, up from 47 in Q3 2017.
  • Funds reported $20.7M of NantHealth, Inc stock for Q4 2017, down 35% quarter-over-quarter.
  • 11 funds opened new NantHealth, Inc positions in Q4 2017 and 6 closed out, a net change of +5 holders.
  • The largest NantHealth, Inc buyer in Q4 2017 was Advisor Group, an estimated $522K added.
  • The largest NantHealth, Inc seller in Q4 2017 was Vanguard Group, an estimated $1.4M sold.

Based on aggregated 13F filings for Q4 2017.